研究用抗体市場：適応症別、操作別、製品別、供給源別、技術別、タイプ別、エンドユーザー別 - 2024年～2030年、世界予測

研究用抗体市場規模は2023年に62億7,000万米ドルと推計され、2024年には67億9,000万米ドルに達し、CAGR 8.43%で2030年には110億5,000万米ドルに達すると予測されます。

研究用抗体市場は、科学研究目的の抗体の生産、流通、応用を中心に展開する世界の産業を指します。抗体は、細菌やウイルスなどの異物を認識しバランスをとるために免疫系によって利用されるタンパク質です。研究においては、抗体はウェスタンブロッティング、フローサイトメトリー、免疫沈降、免疫蛍光、ELISAなど複数の用途に使用されます。これらの抗体の最終用途は通常、製薬会社やバイオテクノロジー企業、学術研究機関、受託研究機関などで見られます。幅広い用途があるため市場規模も大きく、多様な研究ニーズに対応した革新的で特異性の高い抗体の開発が求められています。研究用抗体市場の成長は、ゲノミクスおよびプロテオミクス研究の人気の高まり、研究用抗体の臨床試験および承認の増加、製薬会社およびバイオテクノロジー企業による研究開発への投資の高まりなど、いくつかの要因に影響されています。しかし、研究用抗体市場は、高品質の研究用抗体の生産・調達コストの高さ、研究用抗体に関連する品質への懸念、抗体生産における動物の使用に関する規制の強化などの課題に直面しています。一方、個別化医療やバイオマーカーの普及、新薬開発への投資や資金調達の増加、従来のポリクローナル抗体から遺伝子組換え抗体へのシフトは、研究用抗体市場に今後数年間の潜在的な可能性をもたらしています。

適応症自己免疫疾患の解明を目的とした免疫学における研究用抗体への嗜好の高まり

免疫学において研究用抗体は、T細胞やB細胞などの細胞タイプ、サイトカインなどのシグナル伝達タンパク質、様々な免疫学的経路など、免疫システムの構成要素を研究するために使用される必須ツールです。免疫学の需要は、自己免疫疾患、アレルギー、免疫不全を理解する必要性によって頻繁に牽引されています。感染症の研究用抗体は、病原体に対する身体の反応を調べたり、病原体そのものを同定し特徴付けるために主に利用されます。一般的に、新興感染症やパンデミックに対抗するための抗体の需要は高いです。効果的な抗体開発は、診断法、ワクチン、治療法の改善につながります。神経生物学分野では、研究用抗体が脳機能、神経変性疾患、精神疾患の研究を促進します。神経細胞マーカー、神経伝達物質、受容体に対する抗体は、特にアルツハイマー病やパーキンソン病などの病気に対して高い需要があります。腫瘍学腫瘍マーカー同定、がん細胞シグナル伝達、免疫腫瘍学など、がん研究に不可欠な抗体です。より効果的ながん診断法や治療法の継続的な探索が需要を牽引しています。幹細胞を対象とした研究用抗体は、幹細胞の同定と分離、幹細胞の種類の区別、分化経路の追跡に使用されます。幹細胞研究は急速に進歩している分野であり、再生医療や発生生物学的研究に需要が集中しています。各分野の指標を比較すると、研究用抗体に対するニーズは、疾患領域の複雑さや各分野の進歩の速度によって大きく異なることがわかる。免疫学と腫瘍学は、自己免疫疾患やがんとの闘いにおける継続的な課題のため、常に需要の高い分野です。逆に感染症は、一般的に新たな健康危機に対応して需要が急増します。神経生物学と幹細胞研究は科学的発見の最前線に分類され、ユニークな研究課題に対処するために高度に専門化された抗体を必要とします。神経生物学における脳や中枢神経系の複雑さや、幹細胞生物学のダイナミックな性質は、抗体メーカーの絶え間ない技術革新を必要とします。

エンドユーザー：製薬・バイオテクノロジー企業における研究用抗体の使用拡大

学術・研究機関では、基礎研究、疾患研究、教育目的など様々な用途で抗体を必要とします。このような機関では、研究テーマの幅が広いため、手頃な価格で多様な特異性や用途を持つ抗体が好まれます。このセグメントでは、教育機関向けの割引や機関取引に重点を置き、大量購入オプションを求めることが多いです。製薬・バイオテクノロジー部門では、創薬や薬剤開発プロセスにおいて、高品質で再現性が高く、有効性が確認された抗体が求められています。彼らのニーズは主に治療用抗体開発、バイオマーカー探索、体外診断に集中しています。そのため、ハイスループットや臨床環境での性能が保証された、高級で特殊な抗体が好まれます。学術・研究機関と製薬・バイオテクノロジー企業を比較した場合、研究用抗体の要件にはいくつかの重要な違いがあります。学術・研究機関では、研究テーマがより多様で変化に富んでいることが多く、そのため、抗体には汎用性と費用対効果が求められます。対照的に、製薬・バイオテクノロジー企業は、特に治療研究や診断において厳しい規制要件に直面するため、抗体の再現性と信頼性を優先します。

地域別の洞察

米国では、主に大手製薬会社の存在、バイオテクノロジーやライフサイエンス分野の研究開発への重点的な取り組み、政府や民間からの多額の投資により、高品質な研究用抗体に対する旺盛な需要が存在します。著名な資金提供機関である国立衛生研究所（NIH）は、生物医学研究を支援するイニシアチブを継続的にとっており、これは抗体市場にプラスの影響を与えています。カナダの市場は、バイオテクノロジー産業の成長と医学研究における政府資金の増加という特徴があります。南米では研究用抗体市場が発展しており、ブラジルやアルゼンチンなどの国々が、ヘルスケアシステムの改善、政府および民間による研究支援の増加、非感染性疾患の増加により、地域の需要を牽引しています。EU諸国は、製薬およびバイオテクノロジー産業が確立しており、学術研究活動も盛んであるため、研究用抗体に対する需要が高いです。しかし、厳しい規制政策が市場の成長に制限を課す可能性があります。ドイツ、英国、フランスをはじめとする欧州諸国では、研究活動におけるイノベーションと持続可能性への注目が依然として中心的な動向となっています。中東の研究用抗体市場は、ヘルスケアと研究インフラへの投資の増加とともに発展しています。アフリカの研究用抗体市場は比較的未開拓であり、大きな成長の可能性を秘めています。APAC地域は、新興経済、ヘルスケア資金の増加、研究分野の拡大により、急速な市場成長を示しています。中国の抗体市場は急成長しており、バイオ医薬品の研究開発に多額の投資が行われているほか、ジェネリック医薬品産業も盛んです。日本は、革新の伝統を持つ確立された製薬セクターがあり、研究用抗体にとって重要な市場となっています。日本は高い研究水準で知られており、顧客は高い特異性と再現性を持つ抗体を求めています。インドは、バイオシミラー研究が急増し、バイオテクノロジー産業が急成長しており、急速に発展している市場です。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、研究用抗体市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、研究用抗体市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.研究用抗体市場の市場規模および予測は？

2.研究用抗体市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.研究用抗体市場の技術動向と規制枠組みは？

4.研究用抗体市場における主要ベンダーの市場シェアは？

5.研究用抗体市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ゲノミクスとプロテオミクス調査の人気の高まり
    • 臨床試験と承認の増加研究用抗体
  • 抑制要因
    • 時間とコストがかかる抗体開発プロセス
  • 機会
    • 個別化医療とバイオマーカーの普及
    • 新薬開発への投資と資金の増加
  • 課題
    • 研究用抗体に関連する品質上の懸念
• 市場セグメンテーション分析
  • 適応症：自己免疫疾患を理解するための免疫学における研究用抗体の好みの増加
  • エンドユーザー：製薬・バイオテクノロジー企業における研究用抗体の使用拡大
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 研究用抗体市場：適応症別

• 免疫学
• 感染症
• 神経生物学
• 腫瘍学
• 幹細胞

第7章 研究用抗体市場：操作別

• 医薬品開発
• ゲノミクス
• プロテオミクス

第8章 研究用抗体市場：製品別

• モノクローナル抗体
• ポリクローナル抗体

第9章 研究用抗体市場：供給源別

• ヤギ
• ねずみ
• うさぎ

第10章 研究用抗体市場：技術別

• 酵素免疫測定法
• フローサイトメトリー
• 免疫蛍光
• 免疫組織化学
• 免疫沈降法
• ウエスタンブロッティング

第11章 研究用抗体市場：タイプ別

• 一次抗体
• 二次抗体

第12章 研究用抗体市場：エンドユーザー別

• 学術研究機関
• 製薬・バイオテクノロジー企業

第13章 南北アメリカの研究用抗体市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋の研究用抗体市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの研究用抗体市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • ダナハー、アブカムの買収を完了
  • アッヴィとビッグハット・バイオサイエンス、人工知能と機械学習を活用した次世代治療用抗体の発見に向けた調査協力を発表
  • AbCelleraとカナダは抗体の製造と調査を強化するために5億米ドル以上を投資する

第17章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. RESEARCH ANTIBODIES MARKET RESEARCH PROCESS
• FIGURE 2. RESEARCH ANTIBODIES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. RESEARCH ANTIBODIES MARKET DYNAMICS
• FIGURE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 24. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 26. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 29. RESEARCH ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 30. RESEARCH ANTIBODIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RESEARCH ANTIBODIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 71. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 72. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 73. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 74. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 75. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 76. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 77. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 78. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 79. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 80. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 83. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 84. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 85. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 86. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 87. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 88. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 89. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 90. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 91. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 92. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 93. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 94. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 95. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 96. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 97. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 98. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 99. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 100. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 101. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 102. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 103. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 104. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 105. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 106. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 107. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 108. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 109. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 110. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 111. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 112. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 113. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 114. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 115. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 116. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 117. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 118. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 119. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 120. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 121. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 122. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 123. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 124. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 125. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 126. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 127. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 128. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 129. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 130. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 131. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 132. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 133. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 134. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 135. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 136. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 137. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 138. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 139. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 140. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 141. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 142. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 143. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 144. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 145. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 146. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 147. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 148. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 149. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 152. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 153. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 154. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 155. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 156. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 157. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 158. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 159. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 160. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 161. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 162. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 163. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 164. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 165. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 166. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 168. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 170. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 171. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 172. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 173. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 174. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 175. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 176. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 177. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 178. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 179. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 180. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 181. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 184. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 185. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 186. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 187. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 188. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 189. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 190. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 191. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 192. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 193. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 194. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 195. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 196. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 197. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 198. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 199. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 200. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 201. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 202. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 203. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 204. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 205. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 206. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 207. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 208. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 209. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 210. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 211. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 212. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 213. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 214. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 215. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 216. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 217. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 218. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 219. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 220. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 221. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 222. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 223. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 224. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 225. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 226. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 227. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 228. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 229. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 230. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 231. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 232. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 233. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 234. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 235. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 236. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 237. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 238. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 239. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 240. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 241. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 242. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 243. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 244. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 245. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 246. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 247. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 248. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 249. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 250. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 251. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 252. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 253. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 254. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 255. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 256. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 257. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 258. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 259. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 260. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 261. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 262. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 263. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 264. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 265. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 266. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 267. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 268. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 269. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 270. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 271. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 272. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 273. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 274. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 275. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 276. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 277. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 278. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 279. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 280. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 281. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 282. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 283. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 284. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 285. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 286. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 287. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 288. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 289. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 290. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 291. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 292. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 293. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 294. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 296. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 297. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 298. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 299. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 300. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 301. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 302. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 303. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 304. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 305. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 306. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 307. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 308. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 309. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 310. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 311. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 312. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 313. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 314. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 315. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 316. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 317. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 318. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 319. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 320. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 321. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 322. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 323. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 324. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 325. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 326. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 327. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 328. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 329. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 330. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 331. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 332. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 333. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 334. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 335. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 336. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 337. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 338. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 339. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 340. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 341. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
• TABLE 342. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
• TABLE 343. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 344. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 345. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 346. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 347. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 348. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 349. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 350. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 351. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 352. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 353. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 354. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 355. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD

[182 Pages Report] The Research Antibodies Market size was estimated at USD 6.27 billion in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030.

The market for research antibodies refers to the global industry that revolves around the production, distribution, and application of antibodies for scientific research purposes. Antibodies are proteins utilized by the immune system to recognize and balance foreign substances, such as bacteria and viruses. In the research context, antibodies can be used in multiple applications, such as western blotting, flow cytometry, immunoprecipitation, immunofluorescence, and ELISA. The end-use for these antibodies is typically found in pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. The broad application base provides a wide market scope, with demand driving the development of innovative and high-specific antibodies for diverse research needs. The growth of the research antibodies market is influenced by several factors, including the rising popularity of genomics and proteomics research, increasing clinical trials and approvals of research antibodies, and heightened investment in R&D by pharmaceutical and biotech firms. However, the research antibodies market faces certain challenges, such as the high cost of production and procurement of high-quality research antibodies, quality concerns associated with research antibodies, and tightening regulations regarding the use of animals in antibody production. On the other hand, the proliferation of personalized medicine and biomarkers, increasing investment and funding for novel drug development, and the shift from traditional polyclonal antibodies to recombinant antibodies present potential opportunities for the research antibodies market in the coming years.

Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases

In immunology, research antibodies are essential tools used to study the components of the immune system, including cell types such as T cells and B cells, signaling proteins, including cytokines, and various immunological pathways. Demand in immunology is frequently driven by the need to understand autoimmune diseases, allergies, and immune deficiencies. Research antibodies for infectious diseases are predominantly utilized to investigate the body's responses to pathogens and to identify and characterize the pathogens themselves. Demand is typically high for antibodies that can help combat emerging infectious diseases and pandemics. Effective antibody development can lead to improved diagnostics, vaccines, and therapies. In the neurobiology segment, research antibodies facilitate the study of brain function, neurodegenerative diseases, and psychiatric disorders. Antibodies against neuronal markers, neurotransmitters, and receptors are in high demand, particularly for illnesses such as Alzheimer's and Parkinson's. Oncology research antibodies are critical for cancer research, including tumor marker identification, cancer cell signaling, and immuno-oncology. Demand is driven by the ongoing search for more effective cancer diagnostics and treatments. Research antibodies directed at stem cells are used to identify and isolate stem cells, differentiate between stem cell types, and track differentiation pathways. Stem cell research is a rapidly progressing field, with demand often focusing on regenerative medicine and developmental biology studies. When comparing indicators across the spectrum, it's apparent that the need for research antibodies varies significantly depending on the complexity of the disease area and the rate of advancements in each field. Immunology and oncology are perennially high-demand sectors due to the ongoing challenges in combating autoimmune diseases and cancer. Conversely, infectious diseases see demand spikes typically in response to emerging health crises. Neurobiology and stem cell research can be categorized as frontiers of scientific discovery, requiring highly specialized antibodies to address unique research challenges. The complexity of the brain and central nervous system in neurobiology and the dynamic nature of stem cell biology necessitates constant innovation from antibody manufacturers.

End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies

Academic and research institutes predominantly require antibodies for various applications such as basic research, disease studies, and educational purposes. These institutions favor antibodies that are both affordable and offer a wide variety of specificities and applications, given the breadth of research topics pursued. This segment often seeks bulk purchasing options, emphasizing educational discounts and institutional deals. The pharmaceutical and biotechnology sector demands high-quality, reproducible, and validated antibodies for drug discovery and development processes. Their needs mainly focus on therapeutic antibody development, biomarker discovery, and in vitro diagnostics. Thus, their preference leans toward premium and specialized antibodies that guarantee performance in high-throughput and clinical settings. When comparing academic and research institutes to pharmaceutical and biotechnology companies, several key differences in research antibody requirements arise. Academic and research institutes often have more diverse and variable research interests, thus seeking versatility and cost-effectiveness in their antibodies. In contrast, pharmaceutical and biotechnology companies prioritize the reproducibility and reliability of antibodies, given the stringent regulatory requirements they face, particularly for therapeutic research and diagnostics.

Regional Insights

In the United States, there is a robust demand for high-quality research antibodies, primarily due to the presence of major pharmaceutical companies, a strong focus on R&D in biotechnology and life sciences, and significant government and private investment. The National Institutes of Health (NIH), a prominent funding body, has a continuing initiative to support biomedical research, which positively impacts the antibody market. Canada's market is characterized by a growing biotechnology industry and increased government funding in medical research. In South America, the research antibodies market is evolving, with countries such as Brazil and Argentina spearheading regional demand due to improving healthcare systems, increased governmental and private support for research, and a rise in non-communicable diseases. EU countries exhibit a strong demand for research antibodies due to well-established pharmaceutical and biotech industries, alongside extensive academic research activities. However, stringent regulatory policies may impose limitations on the market's growth. Focus on innovation and sustainability within research practices remains a central trend in European countries, including Germany, the UK, and France. The research antibody market in the Middle East is evolving with increasing investment in healthcare and research infrastructure. Africa's research antibody market is relatively untapped, with significant potential for growth. The APAC region exhibits rapid market growth due to emerging economies, increased healthcare funding, and expanding research sectors. China's antibody market is rapidly growing, with significant investments in biopharmaceutical R&D and a flourishing generics industry. Japan has an established pharmaceutical sector with a tradition of innovation, making it a significant market for research antibodies. Japan is known for its high standards in research practices, leading customers to demand antibodies with high specificity and reproducibility. India presents a rapidly evolving market with a surge in biosimilar research and a burgeoning biotech industry.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Research Antibodies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Research Antibodies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Absolute Antibody Ltd., Agilent Technologies, Inc., AvantGen, Inc., Becton, Dickinson and Company, Bio X Cell, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., Danaher Corporation, Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, GenScript Corporation, Jackson ImmunoResearch Inc., Merck KGaA, PerkinElmer, Inc., PROGEN Biotechnik GmbH, Proteintech Group, Inc., QIAGEN N.V., Santa Cruz Biotechnology Inc., Synaptic Systems GmbH, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Research Antibodies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Indication
  • Immunology
  • Infectious Diseases
  • Neurobiology
  • Oncology
  • Stem Cells

• Operation
  • Drug Development
  • Genomics
  • Proteomics

• Product
  • Monoclonal Antibodies
  • Polyclonal Antibodies

• Source
  • Goat
  • Mouse
  • Rabbit

• Technology
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Immunofluorescence
  • Immunohistochemistry
  • Immunoprecipitation
  • Western Blotting

• Type
  • Primary Antibodies
  • Secondary Antibodies

• End User
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Research Antibodies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Research Antibodies Market?

3. What are the technology trends and regulatory frameworks in the Research Antibodies Market?

4. What is the market share of the leading vendors in the Research Antibodies Market?

5. Which modes and strategic moves are suitable for entering the Research Antibodies Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Popularity of Genomics and Proteomics Research
    • 5.1.1.2. Increasing Clinical Trials and Approvals of Research Antibodies
  • 5.1.2. Restraints
    • 5.1.2.1. Time and Cost Consuming Antibody Development Processes
  • 5.1.3. Opportunities
    • 5.1.3.1. Proliferation of Personalized Medicine and Biomarkers
    • 5.1.3.2. Increasing Investment and Funding for Novel Drug Development
  • 5.1.4. Challenges
    • 5.1.4.1. Quality Concerns Associated with Research Antibodies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases
  • 5.2.2. End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Research Antibodies Market, by Indication

• 6.1. Introduction
• 6.2. Immunology
• 6.3. Infectious Diseases
• 6.4. Neurobiology
• 6.5. Oncology
• 6.6. Stem Cells

7. Research Antibodies Market, by Operation

• 7.1. Introduction
• 7.2. Drug Development
• 7.3. Genomics
• 7.4. Proteomics

8. Research Antibodies Market, by Product

• 8.1. Introduction
• 8.2. Monoclonal Antibodies
• 8.3. Polyclonal Antibodies

9. Research Antibodies Market, by Source

• 9.1. Introduction
• 9.2. Goat
• 9.3. Mouse
• 9.4. Rabbit

10. Research Antibodies Market, by Technology

• 10.1. Introduction
• 10.2. Enzyme-Linked Immunosorbent Assay
• 10.3. Flow Cytometry
• 10.4. Immunofluorescence
• 10.5. Immunohistochemistry
• 10.6. Immunoprecipitation
• 10.7. Western Blotting

11. Research Antibodies Market, by Type

• 11.1. Introduction
• 11.2. Primary Antibodies
• 11.3. Secondary Antibodies

12. Research Antibodies Market, by End User

• 12.1. Introduction
• 12.2. Academic & Research Institutes
• 12.3. Pharmaceutical & Biotechnology Companies

13. Americas Research Antibodies Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Research Antibodies Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Research Antibodies Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Danaher Completes Acquisition of Abcam
  • 16.3.2. AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
  • 16.3.3. AbCellera and Canada to invest $500M+ to boost antibody manufacturing and research

17. Competitive Portfolio

• 17.1. Key Company Profiles
• 17.2. Key Product Portfolio